APA Citation

Feng, J., Lu, P., Zhu, G., Hooi, S. C., Wu, Y., Huang, X., . . . Lu, G. (2020). ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma. Acta Pharmacol Sin.

Chicago Style Citation

Feng, Ji, et al. "ACSL4 Is a Predictive Biomarker of Sorafenib Sensitivity in Hepatocellular Carcinoma." Acta Pharmacol Sin 2020.

MLA Citation

Feng, Ji, et al. "ACSL4 Is a Predictive Biomarker of Sorafenib Sensitivity in Hepatocellular Carcinoma." Acta Pharmacol Sin 2020.

Warning: These citations may not always be 100% accurate.